and still only half the MC of RAC, $175m.
Interesting article above, note the comments around lower selling prices outside of the US. Showing the importance of being there, at least in the clinic.
Amgens debt balance sheet will be $37B after the two transactions, surely these companies appetites for debt stop at some point; hopefully RAC get cracking before they spend all the spare cash.
Industry news, page-876
-
- There are more pages in this discussion • 934 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.005(0.29%) |
Mkt cap ! $297.1M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.74 | $22.50K | 12.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 492 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 650 | 1 |
View Market Depth
| Last trade - 10.30am 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |